Search bioRxivSearch

bioRxiv · 10.1101/2020.04.10.035311

Adaptive evolution of olfactory degeneration in recently flightless insects

Abstract

Fast-moving animals need fast-acting sensory systems. Flying insects have thus evolved exceptionally quick visual (1) and olfactory processing ability (2). For example, flighted insects can track the temporal structure of turbulent odor plumes at rates above 100 Hz (3). The evolutionary lability of such sensory systems, however, remains unknown. We test for rapid evolutionary shifts in olfactory processing speed associated with flight loss, through neurobiological comparisons of sympatric flighted versus flightless lineages within a wing-polymorphic stonefly species. Our analyses of sensory responses reveal that recently-evolved flightless lineages have substantially degraded olfactory acuity. By comparing flighted versus flightless ecotypes with similar genetic backgrounds (4), we eliminate other confounding factors that might have affected the evolution of their olfactory reception mechanisms. Our detection of different patterns of degraded olfactory sensitivity and speed in independently wing-reduced lineages highlights parallel evolution of sensory degeneration. These reductions in sensory ability also echo the rapid vestigialization of wings themselves (4, 5), and represent a neurobiological parallel to the convergent phenotypic shifts seen under sharp selective gradients in other systems (e.g. parallel loss of vision in diverse cave fauna (6)). Our study provides the first direct evidence for the hypothesis that flight poses a selective pressure on the speed of olfactory receptor neurons. Our findings also emphasize the energetic costs of rapid olfaction, and the key role of natural selection in shaping dramatic neurobiological shifts. Significance StatementFlying insects move fast and have therefore evolved exceptionally quick-acting sensory systems. The speed with which such neurobiological shifts can evolve, however, remains unclear. Under the use it or lose it hypothesis, loss of flight should lead to degradation of this fast sensory processing ability. We test for evolutionary reductions in olfactory acuity linked to flight loss, through neurobiological comparisons of flightless versus flighted lineages within a wing-polymorphic insect. Our analyses reveal that newly wing-reduced populations have substantially degraded olfactory acuity, with parallel reductions in this sensory ability detected in independently flightless lineages. These findings reveal that flight poses strong selective pressure for rapid olfaction, and highlight the potential of natural selection in rapidly shaping adaptive shifts in animal sensory systems.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Neupert, S., McCulloch, G. A., Foster, B. J., Waters, J. M., Szyszka, P.. 2020-04-10. Adaptive evolution of olfactory degeneration in recently flightless insects. https://doi.org/10.1101/2020.04.10.035311

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience